Dr. Osman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3660 Vista Ave
Saint Louis, MO 63110Phone+1 314-577-8047Fax+1 314-268-5116
Education & Training
- Johns Hopkins University School of MedicineFellowship, PET/CT, 2001 - 2002
- Johns Hopkins UniversityResidency, Nuclear Medicine, 1999 - 2001
- University of Assiut Faculty of MedicineClass of 1985
Certifications & Licensure
- MO State Medical License 2002 - 2026
- IL State Medical License 2005 - 2014
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- Prostate Cancer Patients With Biochemical Recurrence Start of enrollment: 2018 Dec 18
Publications & Presentations
PubMed
- F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.Medhat M Osman, Amir Iravani, Catherine Mitchell, Rodney J Hicks, Elisa Perry
Journal of Nuclear Medicine. 2024-09-03 - Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Ve...Aileen Green, Peter Temsah, Leonard Goldfarb, Leonard Goldfarb, Kristen Sanfolippo
Nuclear Medicine Communications. 2024-06-01 - Incidence of 99Tc-MDP uptake in the external occipital protuberance in the pediatric population: the new normal?Razi Muzaffar, Amer Alassi, Mohamed Mashal, Medhat M Osman
American Journal of Nuclear Medicine and Molecular Imaging. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: